Vest Financial LLC Acquires 3,679 Shares of Intuitive Surgical, Inc. $ISRG

Vest Financial LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 45.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 11,833 shares of the medical equipment provider’s stock after purchasing an additional 3,679 shares during the period. Vest Financial LLC’s holdings in Intuitive Surgical were worth $6,702,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Oakworth Capital Inc. lifted its stake in shares of Intuitive Surgical by 281.3% in the 4th quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 45 shares during the last quarter. Wealthfront Advisers LLC grew its holdings in shares of Intuitive Surgical by 15.4% during the fourth quarter. Wealthfront Advisers LLC now owns 46,256 shares of the medical equipment provider’s stock worth $26,198,000 after purchasing an additional 6,180 shares during the last quarter. Torren Management LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at approximately $67,000. Ares Financial Consulting LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $82,000. Finally, Mitsubishi UFJ Trust & Banking Corp grew its stake in shares of Intuitive Surgical by 3.6% in the fourth quarter. Mitsubishi UFJ Trust & Banking Corp now owns 255,523 shares of the medical equipment provider’s stock worth $144,718,000 after purchasing an additional 8,891 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Mark Brosius sold 2,362 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the sale, the senior vice president directly owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 5,413 shares of company stock valued at $2,681,362 in the last three months. 0.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts recently commented on ISRG shares. JPMorgan Chase & Co. reduced their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price on the stock in a research report on Wednesday, March 11th. BTIG Research reiterated a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Piper Sandler cut their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Argus dropped their price target on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $581.91.

Intuitive Surgical Trading Down 0.9%

NASDAQ ISRG opened at $466.64 on Wednesday. The business has a fifty day simple moving average of $476.64 and a 200 day simple moving average of $516.83. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88. The firm has a market capitalization of $165.27 billion, a P/E ratio of 56.56, a PEG ratio of 3.79 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the previous year, the firm earned $1.81 EPS. The business’s revenue for the quarter was up 23.0% compared to the same quarter last year. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 8.5 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.